Brussels antitrust and competition partners Simon Baxter and Ingrid Vandenborre chaired panels at "Competition Summit 2013," to be held December 5-6 in Brussels. On December 5, Mr. Baxter moderated "Remedies Package: Getting It Right for Approval," focusing on such topics as effectiveness and proportionality, displaying a thorough market study, market share, choice of remedies and market testing remedies. On December 6, Ms. Vandenborre chaired "Generics: Are They Increasing or Decreasing Drugs' Prices?" — a session concerning potential adverse and pro-competitive effects of patent settlements, criteria for abuses of patent settlements, short-run exclusivity restrictions and the potential cost for consumers from delays in generic entry on the market, among other topics.

BACK TO TOP